Alyeska Investment Group, L.P. Vbi Vaccines Inc Transaction History

Alyeska Investment Group, L.P.

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q2 2020 Aug 14, 2020	SELL	$0.87 - $3.13 $1.19 Million - $4.27 Million	-1,363,627 Reduced 86.11%	219,975 $681,000
Q3 2019 Nov 14, 2019	BUY	$0.47 - $1.05 $744,292 - $1.66 Million	1,583,602 New	1,583,602 $744,000

688K

Ticker VBIV
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 258,256,992
Market Cap $5.17M
Description
VBI Vaccines Inc., a biopharmaceutical company, develops and sells vaccines for the treatment of infectious diseases and immuno-oncology. The company offers Sci-B-Vac, a prophylactic hepatitis B (HBV) vaccine. It also engages in the development of VBI-2601 (BRII-179), an immunotherapeutic candidate for the treatment of chronic HBV infection. The...

Get notified when there are updates to the investment portfolio of Alyeska Investment Group, L.P., based on Form 13F filings with the SEC.

Stay updated on Alyeska Investment Group, L.P. with notifications on news.